Yu-Hsin Lin sold $19M of BLTE
Chief Executive Officer at BELITE BIO, INC. 100,435 shares at an average of $190.00, traded Sep 4, 2026, filed Sep 9, 2026.
Score components
- +25RoleCEO
- +25Trade size$19.1M at market
- +20Share of holdings soldSold 59% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-386794, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -2,635 | $180.29 | $475k | 167,934 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -2,587 | $181.24 | $469k | 165,347 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -3,413 | $182.50 | $623k | 161,934 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -4,955 | $183.30 | $908k | 156,979 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -6,252 | $184.52 | $1.2M | 150,727 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -4,593 | $185.34 | $851k | 146,134 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -7,800 | $186.32 | $1.5M | 138,334 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -6,200 | $187.25 | $1.2M | 132,134 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -3,045 | $188.26 | $573k | 129,089 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -8,955 | $189.34 | $1.7M | 120,134 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -600 | $190.39 | $114k | 119,534 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -11,080 | $191.15 | $2.1M | 108,454 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -4,209 | $192.54 | $810k | 104,245 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -8,111 | $193.13 | $1.6M | 96,134 | 35 d ago |
| Sep 8, 2026 | SOpen-market sale American depositary share10b5-1 | -2,400 | $194.33 | $466k | 93,734 | 35 d ago |
| Sep 8, 2026 | SOpen-market sale American depositary share10b5-1 | -6,090 | $195.62 | $1.2M | 87,644 | 35 d ago |
| Sep 8, 2026 | SOpen-market sale American depositary share10b5-1 | -6,058 | $196.54 | $1.2M | 81,586 | 35 d ago |
| Sep 8, 2026 | SOpen-market sale American depositary share10b5-1 | -8,752 | $197.36 | $1.7M | 72,834 | 35 d ago |
| Sep 8, 2026 | SOpen-market sale American depositary share10b5-1 | -2,700 | $198.09 | $535k | 70,134 | 35 d ago |
Related signals
Other insiders at BELITE BIO, INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 4Weak | BELITE BIO, INC | Hendrik Peter Scholl Chief Medical Officer | $83k 500 shares | -3% | |
| 55Moderate | BELITE BIO, INC | Hao-Yuan Chuang Chief Financial Officer | $13M 67,395 shares | -72% | |
| 21Weak | BELITE BIO, INC | Yu-Hsin Lin Chief Executive Officer | $66k 365 shares | -0% | |
| 18Weak | BELITE BIO, INC | Hao-Yuan Chuang Chief Financial Officer | $66k 367 shares | -0% | |
| 50Moderate | BLTEsell BELITE BIO, INC | Hendrik Peter Scholl Chief Medical Officer | $1.5M 10,000 shares | -40% | |
| 50Moderate | BLTEsell BELITE BIO, INC | Hendrik Peter Scholl Chief Medical Officer | $1.4M 10,000 shares | -29% | |
| 25Weak | BELITE BIO, INC | Nathan L. Mata Chief Scientific Officer | $102k 666 shares | -100% | |
| 26Weak | BELITE BIO, INC | Nathan L. Mata Chief Scientific Officer | $154k 1,000 shares | -60% | |
| 16Weak | BELITE BIO, INC | Nathan L. Mata Chief Scientific Officer | $156k 1,000 shares | -38% | |
| 16Weak | BELITE BIO, INC | Nathan L. Mata Chief Scientific Officer | $156k 1,000 shares | -27% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.